• A study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn’s disease or ulcerative colitis

    Not recruiting

    2 1
    Investigated Diseases:
    Austria Belgium Bulgaria Croatia Czechia France +8
  • A study of ketamine hydrochloride as an additional treatment for patients starting standard antidepressants for major depression

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden
  • A study to evaluate the safety of REGN7041 in adults with active noninfectious uveitis affecting the back of the eye.

    Not recruiting

    2 1 1
    Investigated Diseases:
    France
  • A study to evaluate the effect of baxdrostat and dapagliflozin in reducing protein in the urine for patients with chronic kidney disease and high blood pressure

    Not recruiting

    2 1 1
    Investigated Drugs:
    Bulgaria Spain
  • Orlistat (EMP22) and Drug Combination (acarbose + orlistat) in Healthy Volunteers with Obesity

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden
  • Evaluation of the Drug‑Drug Interaction Between Ramipril and Indapamide in Healthy Volunteers

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia
  • A study to compare how the body absorbs celecoxib oral suspension and celecoxib capsules in healthy adults for the treatment of acute pain.

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia
  • Effect of itraconazole on the pharmacokinetics of BI 1584862 in healthy male volunteers

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    Germany
  • Evaluation of HLX10 Combined with Chemotherapy and Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized, Double-Blind Study

    Not recruiting

    3 1 1
    Investigated Diseases:
    Austria Czechia Germany Greece Hungary Latvia +3
  • Evaluation of Safety, Tolerability, and Biodistribution of Inhaled RCT2100 in Cystic Fibrosis: A Phase 1/2 Multicenter Study

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France The Netherlands

powered by